Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cardiotoxicity Surveillance and Risk of Heart Failure During HER2 Targeted Therapy

Published:2020-06 Issue:2 Volume:2 Page:166-175
ISSN:2666-0873
Container-title:JACC: CardioOncology
language:en
Short-container-title:JACC: CardioOncology

Author:

Yu Anthony F.,Moskowitz Chaya S.,Lee Chuy Katherine,Yang Ji,Dang Chau T.,Liu Jennifer E.,Oeffinger Kevin C.,Steingart Richard M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Oncology

Reference25 articles.

1. Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer;Yu;Breast Cancer Res Treat,2015

2. Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

3. Adjuvant trastuzumab in HER2-positive breast cancer;Slamon;N Engl J Med,2011

4. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer;Romond;N Engl J Med,2005

5. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline;Armenian;J Clin Oncol,2017

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strain surveillance during chemotherapy to improve cardiovascular outcomes: the SUCCOUR-MRI trial;European Heart Journal;2024-09-01

2. Major adverse cardiovascular events in advanced-stage lung cancer: a multicenter cohort study;Therapeutic Advances in Medical Oncology;2024-01

3. Multimodal Imaging of Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer—A State-of-the-Art Review;Journal of Clinical Medicine;2023-09-29

4. Does cardiac imaging surveillance strategy influence outcomes in patients with early breast cancer?;Frontiers in Oncology;2023-06-27

5. Quantitative cardiovascular magnetic resonance findings and clinical risk factors predict cardiovascular outcomes in breast cancer patients;PLOS ONE;2023-05-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3